With the analysis among 914 patents, we discovered top 77 key players by total patent application. Amgen, Inc., Regeneron Pharmaceuticals, Inc., Novartis AG are dominant in this area. They take 39.72% of the total patent filing.
California, United States
Patent: 167
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 135
Basel-Stadt, Switzerland
Patent: 61
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 45
New York, United States
Patent: 30
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 28
New York, United States
Patent: 26
Roche Innovation Center Copenhagen A/S
Hovedstaden, Denmark
Patent: 25
California, United States
Patent: 24
Pennsylvania, United States
Patent: 24
With the analysis among 7 patents, we discovered top 2 start-ups by total patent application.
Institut National de la Santé et de la Recherche Médicale
Anji Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 3
With the analysis among related 270 patents applied in the last 5 years. We discover 50 most active companies in this area. The fast-growing Novartis AG, Regeneron Pharmaceuticals, Inc., Amgen, Inc. take 28.15% of patent filing during this period.
Basel-Stadt, Switzerland
Patent: 29
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 29
California, United States
Patent: 18
New York, United States
Patent: 15
Cambridgeshire, United Kingdom
Patent: 13
Suzhou Ruibo Biological Technology Co Ltd
Jiangsu Sheng, China
Patent: 10
Innovent Biologics (Suzhou) Co. Ltd.
Jiangsu Sheng, China
Patent: 9
Shanghai Junshi Biosciences Co., Ltd.
Shanghai Shi, China
Patent: 8
Suzhou Junmeng Biomedical Technology Co., Ltd.
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 8
With the analysis among related 270 patents in last 5 years, we discover 30 new entrants. Suzhou Ruibo Biological Technology Co Ltd, LIB Therapeutics LLC, Ra Pharmaceuticals, Inc. are the most active new entrants in this area.
Suzhou Ruibo Biological Technology Co Ltd
Jiangsu Sheng, China
Patent: 10
Delaware, United States
Patent: 8
Massachusetts, United States
Patent: 8
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 6
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 5
BRISTOL, United Kingdom
Patent: 5
Massachusetts, United States
Patent: 5
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 5
With the analysis among 74 patents, we discovered top 12 universities and scientific research institutions by total patent application. Shanghai Institute of Materia Medica Chinese Academy of Sciences, University of Bordeaux 1, McGill University are dominant in this area. They take 41.89% of the total patent filing.
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 4
Bretagne, France
Patent: 3
Philipps University of Marburg
New Jersey Institute of Technology
New Jersey, United States
Patent: 2
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 2
École Polytechnique Fédérale de Lausanne
Vaud, Switzerland
Patent: 1
Chongqing Medical University
Chongqing Shi, China
Patent: 1
LORRAINE, France
Patent: 1
Institut National de la Recherche Scientifique